Civic

Join us for two events at the University of Maryland BioPark focused around the health and sciences sector. How do we work together to ensure Baltimore's vibrant health and sciences community continues to grow, innovate and thrive?

Monday, September 28 8am–3pm

Track Day Events

  • Health & Sciences Lunchtime Roundtable

    How do we work together to ensure Baltimore's vibrant health and sciences community continues to grow, innovate and thrive? Participate in an intimate lunch with a curated group of entrepreneurs, investors, policy makers, academics and leaders to discuss plans for the future and steps to get there.

    Monday, September 28, 11:30am–1:00pm
  • Switch Baltimore

    Interested in the trends in health and sciences focused around the Baltimore region? Join us for Switch Baltimore on Monday, Sept 28th as we "switch" up the conversation and focus on the future of Health & Science IT.

    Monday, September 28, 1:00pm–4:00pm

Speakers

  • Patrick Dougherty

    Patrick Dougherty

    Patrick joined the Economic Alliance of Greater Baltimore in June 2012, where he is currently responsible for directing the research efforts of the organization. In his time with EAGB, Patrick has authored State of the Market Reports covering Cyber Security and BioHealth in Greater Baltimore

  • Mary Morris

    Mary Morris

    As the EAGB’s Commercialization & Innovation Specialist, Mary focuses on the development of industry specific innovation strategies and best practices, working closely with EAGB’s state and local partners and the region’s business, government and higher education leaders.

  • Dr. Christopher W. Kersey

    Dr. Christopher W. Kersey

    Christopher W. Kersey is a Partner and Managing Member of Camden Partners, where he focuses on private equity investments in the health care and business services industries. Dr. Kersey serves as the Chairman of the Board of Johns Hopkins Medicine International, the development arm of Johns

  • M. Jason Brooke

    M. Jason Brooke

    M. Jason Brooke is the Chief Executive Officer and General Counsel for Vasoptic Medical Inc., an early stage medical device company developing a mobile health solution for early detection of diabetic retinopathy. Mr. Brooke has more than 10 years of experience in design, development, and

  • Miriam Boer

    Miriam Boer

    Miriam Boer is the founder and CTO of Sonify Biosciences. A biochemist by training, she drives Sonify's pioneering research in developing a device using low intensity ultrasound to treat melanoma and other skin cancers. She has extensive experience starting non-spinout biotech companies and

University of Maryland BioPark
801 West Baltimore Street

Track Supported by

Track Collaborators